Financial Metrics

MDT Medtronic plc

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-01-29	0.77	—	USD/shares	10-Q	2017-03-03
Quarterly	2016-07-29	0.66	-14.3%	USD/shares	10-Q	2017-09-01
Quarterly	2016-10-28	0.8	+21.2%	USD/shares	10-Q	2017-12-04
Quarterly	2017-01-27	0.59	-26.3%	USD/shares	10-Q	2018-03-02
Quarterly	2017-07-28	0.74	+25.4%	USD/shares	10-Q	2018-08-31
Quarterly	2017-10-27	1.48	+100.0%	USD/shares	10-Q	2018-11-29
Quarterly	2018-01-26	-1.03	-169.6%	USD/shares	10-Q	2019-03-01
Quarterly	2018-07-27	0.79	+176.7%	USD/shares	10-Q	2019-08-30
Quarterly	2018-10-26	0.82	+3.8%	USD/shares	10-Q	2019-12-03
Quarterly	2019-01-25	0.94	+14.6%	USD/shares	10-Q	2020-02-28
Quarterly	2019-07-26	0.64	-31.9%	USD/shares	10-Q	2020-09-03
Quarterly	2019-10-25	1.01	+57.8%	USD/shares	10-Q	2020-12-03
Quarterly	2020-01-24	1.42	+40.6%	USD/shares	10-Q	2021-03-05
Quarterly	2020-07-31	0.36	-74.6%	USD/shares	10-Q	2021-09-02
Quarterly	2020-10-30	0.36	+0.0%	USD/shares	10-Q	2021-12-02
Quarterly	2021-01-29	0.94	+161.1%	USD/shares	10-Q	2022-03-03
Quarterly	2021-07-30	0.56	-40.4%	USD/shares	10-Q	2022-09-01
Quarterly	2021-10-29	0.97	+73.2%	USD/shares	10-Q	2022-12-01
Quarterly	2022-01-28	1.1	+13.4%	USD/shares	10-Q	2023-03-01
Quarterly	2022-07-29	0.7	-36.4%	USD/shares	10-Q	2023-08-31
Quarterly	2022-10-28	0.32	-54.3%	USD/shares	10-Q	2023-11-30
Quarterly	2023-01-27	0.92	+187.5%	USD/shares	10-Q	2024-02-27
Quarterly	2023-07-28	0.59	-35.9%	USD/shares	10-Q	2024-08-27
Quarterly	2023-10-27	0.68	+15.3%	USD/shares	10-Q	2024-11-26
Quarterly	2024-01-26	0.99	+45.6%	USD/shares	10-Q	2025-02-25
Quarterly	2024-07-26	0.8	-19.2%	USD/shares	10-Q	2025-08-26
Quarterly	2024-10-25	0.99	+23.7%	USD/shares	10-Q	2025-11-25
Quarterly	2025-01-24	1.01	+2.0%	USD/shares	10-Q	2026-02-24
Quarterly	2025-07-25	0.81	-19.8%	USD/shares	10-Q	2025-08-26
Quarterly	2025-10-24	1.07	+32.1%	USD/shares	10-Q	2025-11-25
Quarterly	2026-01-23	0.89	-16.8%	USD/shares	10-Q	2026-02-24
Annual	2016-10-28	0.8	—	USD/shares	10-K	2018-06-22
Annual	2017-10-27	1.48	+85.0%	USD/shares	10-K	2019-06-21
Annual	2018-10-26	0.82	-44.6%	USD/shares	10-K	2020-06-19
Annual	2019-10-25	1.01	+23.2%	USD/shares	10-K	2020-06-19
Annual	2020-04-24	3.54	+250.5%	USD/shares	10-K	2022-06-23
Annual	2021-04-30	2.66	-24.9%	USD/shares	10-K	2023-06-22
Annual	2022-04-29	3.73	+40.2%	USD/shares	10-K	2024-06-20
Annual	2023-04-28	2.82	-24.4%	USD/shares	10-K	2025-06-20
Annual	2024-04-26	2.76	-2.1%	USD/shares	10-K	2025-06-20
Annual	2025-04-25	3.61	+30.8%	USD/shares	10-K	2025-06-20

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Annual	2016-04-29	29944000000.0	—	USD	10-K	2016-06-28
Annual	2017-04-28	25874000000.0	-13.6%	USD	10-K	2017-06-27
Annual	2018-04-27	23692000000.0	-8.4%	USD	10-K	2018-06-22
Annual	2019-04-26	24552000000.0	+3.6%	USD	10-K	2019-06-21
Annual	2020-04-24	22140000000.0	-9.8%	USD	10-K	2020-06-19

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-01-29	693000000.0	—	USD	10-Q	2017-03-03
Quarterly	2016-07-29	330000000.0	-52.4%	USD	10-Q	2017-09-01
Quarterly	2016-10-28	598000000.0	+81.2%	USD	10-Q	2017-12-04
Quarterly	2017-01-27	924000000.0	+54.5%	USD	10-Q	2018-03-02
Quarterly	2017-07-28	278000000.0	-69.9%	USD	10-Q	2018-08-31
Quarterly	2017-10-27	524000000.0	+88.5%	USD	10-Q	2018-11-29
Quarterly	2018-01-26	776000000.0	+48.1%	USD	10-Q	2019-03-01
Quarterly	2018-07-27	291000000.0	-62.5%	USD	10-Q	2019-08-30
Quarterly	2018-10-26	497000000.0	+70.8%	USD	10-Q	2019-12-03
Quarterly	2019-01-25	799000000.0	+60.8%	USD	10-Q	2020-02-28
Quarterly	2019-07-26	301000000.0	-62.3%	USD	10-Q	2020-09-03
Quarterly	2019-10-25	584000000.0	+94.0%	USD	10-Q	2020-12-03
Quarterly	2020-01-24	877000000.0	+50.2%	USD	10-Q	2021-03-05
Quarterly	2020-07-31	334000000.0	-61.9%	USD	10-Q	2021-09-02
Quarterly	2020-10-30	615000000.0	+84.1%	USD	10-Q	2021-12-02
Quarterly	2021-01-29	978000000.0	+59.0%	USD	10-Q	2022-03-03
Quarterly	2021-07-30	378000000.0	-61.3%	USD	10-Q	2022-09-01
Quarterly	2021-10-29	649000000.0	+71.7%	USD	10-Q	2022-12-01
Quarterly	2022-01-28	979000000.0	+50.8%	USD	10-Q	2023-03-01
Quarterly	2022-07-29	426000000.0	-56.5%	USD	10-Q	2023-08-31
Quarterly	2022-10-28	749000000.0	+75.8%	USD	10-Q	2023-11-30
Quarterly	2023-01-27	1081000000.0	+44.3%	USD	10-Q	2024-02-27
Quarterly	2023-07-28	354000000.0	-67.3%	USD	10-Q	2024-08-27
Quarterly	2023-10-27	815000000.0	+130.2%	USD	10-Q	2024-11-26
Quarterly	2024-01-26	1161000000.0	+42.5%	USD	10-Q	2025-02-25
Quarterly	2024-07-26	520000000.0	-55.2%	USD	10-Q	2025-08-26
Quarterly	2024-10-25	924000000.0	+77.7%	USD	10-Q	2025-11-25
Quarterly	2025-01-24	1400000000.0	+51.5%	USD	10-Q	2026-02-24
Quarterly	2025-07-25	504000000.0	-64.0%	USD	10-Q	2025-08-26
Quarterly	2025-10-24	972000000.0	+92.9%	USD	10-Q	2025-11-25
Quarterly	2026-01-23	1416000000.0	+45.7%	USD	10-Q	2026-02-24
Annual	2016-04-29	1046000000.0	—	USD	10-K	2018-06-22
Annual	2017-04-28	1254000000.0	+19.9%	USD	10-K	2019-06-21
Annual	2018-04-27	1068000000.0	-14.8%	USD	10-K	2020-06-19
Annual	2019-04-26	1134000000.0	+6.2%	USD	10-K	2021-06-25
Annual	2020-04-24	1213000000.0	+7.0%	USD	10-K	2022-06-23
Annual	2021-04-30	1355000000.0	+11.7%	USD	10-K	2023-06-22
Annual	2022-04-29	1368000000.0	+1.0%	USD	10-K	2024-06-20
Annual	2023-04-28	1459000000.0	+6.7%	USD	10-K	2025-06-20
Annual	2024-04-26	1587000000.0	+8.8%	USD	10-K	2025-06-20
Annual	2025-04-25	1859000000.0	+17.1%	USD	10-K	2025-06-20

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-01-29	1422200000.0	—	shares	10-Q	2017-03-03
Quarterly	2016-07-29	1407100000.0	-1.1%	shares	10-Q	2017-09-01
Quarterly	2016-10-28	1392500000.0	-1.0%	shares	10-Q	2017-12-04
Quarterly	2017-01-27	1383100000.0	-0.7%	shares	10-Q	2018-03-02
Quarterly	2017-07-28	1375600000.0	-0.5%	shares	10-Q	2018-08-31
Quarterly	2017-10-27	1365800000.0	-0.7%	shares	10-Q	2018-11-29
Quarterly	2018-01-26	1354000000.0	-0.9%	shares	10-Q	2019-03-01
Quarterly	2018-07-27	1365400000.0	+0.8%	shares	10-Q	2019-08-30
Quarterly	2018-10-26	1360900000.0	-0.3%	shares	10-Q	2019-12-03
Quarterly	2019-01-25	1352700000.0	-0.6%	shares	10-Q	2020-02-28
Quarterly	2019-07-26	1351900000.0	-0.1%	shares	10-Q	2020-09-03
Quarterly	2019-10-25	1351400000.0	-0.0%	shares	10-Q	2020-12-03
Quarterly	2020-01-24	1351500000.0	+0.0%	shares	10-Q	2021-03-05
Quarterly	2020-07-31	1350000000.0	-0.1%	shares	10-Q	2021-09-02
Quarterly	2020-10-30	1352100000.0	+0.2%	shares	10-Q	2021-12-02
Quarterly	2021-01-29	1356000000.0	+0.3%	shares	10-Q	2022-03-03
Quarterly	2021-07-30	1356400000.0	+0.0%	shares	10-Q	2022-09-01
Quarterly	2021-10-29	1355300000.0	-0.1%	shares	10-Q	2022-12-01
Quarterly	2022-01-28	1350300000.0	-0.4%	shares	10-Q	2023-03-01
Quarterly	2022-07-29	1334500000.0	-1.2%	shares	10-Q	2023-08-31
Quarterly	2022-10-28	1332000000.0	-0.2%	shares	10-Q	2023-11-30
Quarterly	2023-01-27	1332000000.0	+0.0%	shares	10-Q	2024-02-27
Quarterly	2023-07-28	1333800000.0	+0.1%	shares	10-Q	2024-08-27
Quarterly	2023-10-27	1331900000.0	-0.1%	shares	10-Q	2024-11-26
Quarterly	2024-01-26	1331700000.0	-0.0%	shares	10-Q	2025-02-25
Quarterly	2024-07-26	1296500000.0	-2.6%	shares	10-Q	2025-08-26
Quarterly	2024-10-25	1286900000.0	-0.7%	shares	10-Q	2025-11-25
Quarterly	2025-01-24	1286200000.0	-0.1%	shares	10-Q	2026-02-24
Quarterly	2025-07-25	1287100000.0	+0.1%	shares	10-Q	2025-08-26
Quarterly	2025-10-24	1288000000.0	+0.1%	shares	10-Q	2025-11-25
Quarterly	2026-01-23	1289500000.0	+0.1%	shares	10-Q	2026-02-24
Annual	2016-04-29	1425900000.0	—	shares	10-K	2018-06-22
Annual	2017-04-28	1391400000.0	-2.4%	shares	10-K	2019-06-21
Annual	2018-04-27	1368200000.0	-1.7%	shares	10-K	2020-06-19
Annual	2019-04-26	1357500000.0	-0.8%	shares	10-K	2021-06-25
Annual	2020-04-24	1351100000.0	-0.5%	shares	10-K	2022-06-23
Annual	2021-04-30	1354000000.0	+0.2%	shares	10-K	2023-06-22
Annual	2022-04-29	1351400000.0	-0.2%	shares	10-K	2024-06-20
Annual	2023-04-28	1332800000.0	-1.4%	shares	10-K	2025-06-20
Annual	2024-04-26	1330200000.0	-0.2%	shares	10-K	2025-06-20
Annual	2025-04-25	1289900000.0	-3.0%	shares	10-K	2025-06-20

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

22,140,000,000

Total Liabilities (latest annual)

43,424,000,000

Current Liabilities (latest annual)

12,879,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-01-29	0.0215	—	ratio	10-Q	2017-03-03
Quarterly	2016-07-29	0.0183	-15.3%	ratio	10-Q	2017-09-01
Quarterly	2016-10-28	0.0221	+21.0%	ratio	10-Q	2017-12-04
Quarterly	2017-01-27	0.0166	-25.0%	ratio	10-Q	2018-03-02
Quarterly	2017-07-28	0.0199	+19.9%	ratio	10-Q	2018-08-31
Quarterly	2017-10-27	0.0390	+96.4%	ratio	10-Q	2018-11-29
Quarterly	2018-01-26	-0.0277	-170.9%	ratio	10-Q	2019-03-01
Quarterly	2018-07-27	0.0214	+177.4%	ratio	10-Q	2020-02-28
Quarterly	2018-10-26	0.0225	+5.3%	ratio	10-Q	2020-02-28
Quarterly	2019-01-25	0.0255	+13.0%	ratio	10-Q	2020-02-28
Quarterly	2019-07-26	0.0174	-31.8%	ratio	10-Q	2021-03-05
Quarterly	2019-10-25	0.0270	+55.6%	ratio	10-Q	2021-03-05
Quarterly	2020-01-24	0.0369	+36.6%	ratio	10-Q	2021-03-05
Quarterly	2020-07-31	0.0097	-73.6%	ratio	10-Q	2022-03-03
Quarterly	2020-10-30	0.0098	+0.9%	ratio	10-Q	2022-03-03
Quarterly	2021-01-29	0.0251	+155.8%	ratio	10-Q	2022-03-03
Quarterly	2021-07-30	0.0149	-40.7%	ratio	10-Q	2023-03-01
Quarterly	2021-10-29	0.0252	+69.6%	ratio	10-Q	2023-03-01
Quarterly	2022-01-28	0.0281	+11.4%	ratio	10-Q	2023-03-01
Quarterly	2022-07-29	0.0176	-37.4%	ratio	10-Q	2024-02-27
Quarterly	2022-10-28	0.0084	-52.6%	ratio	10-Q	2024-02-27
Quarterly	2023-01-27	0.0238	+184.9%	ratio	10-Q	2024-02-27
Quarterly	2023-07-28	0.0155	-34.8%	ratio	10-Q	2025-02-25
Quarterly	2023-10-27	0.0176	+13.7%	ratio	10-Q	2025-02-25
Quarterly	2024-01-26	0.0257	+45.8%	ratio	10-Q	2025-02-25
Quarterly	2024-07-26	0.0218	-15.3%	ratio	10-Q	2026-02-24
Quarterly	2024-10-25	0.0262	+20.4%	ratio	10-Q	2026-02-24
Quarterly	2025-01-24	0.0263	+0.1%	ratio	10-Q	2026-02-24
Quarterly	2025-07-25	0.0218	-17.2%	ratio	10-Q	2026-02-24
Quarterly	2025-10-24	0.0283	+29.9%	ratio	10-Q	2026-02-24
Quarterly	2026-01-23	0.0234	-17.3%	ratio	10-Q	2026-02-24
Annual	2020-04-24	0.0945	—	ratio	10-K	2022-06-23
Annual	2021-04-30	0.0703	-25.5%	ratio	10-K	2023-06-22
Annual	2022-04-29	0.0960	+36.5%	ratio	10-K	2024-06-20
Annual	2023-04-28	0.0732	-23.7%	ratio	10-K	2025-06-20
Annual	2024-04-26	0.0735	+0.3%	ratio	10-K	2025-06-20
Annual	2025-04-25	0.0972	+32.3%	ratio	10-K	2025-06-20

8-K Material Event Details

53 filings · 109 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

554 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-03-03	Pieton Thierry	EVP & Chief Financial Officer	Other disposed transaction F	Ordinary Shares	2,976	$96.71	$287,809	37,574
2026-02-20	Blomquist Denise L.	Chief Accounting Officer	Equity grant / award G	Ordinary Shares	340	$0.00	$0	11,966
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Exercise / conversion M · derivative	Stock Option (Right to Buy)	385	$0.00	$0	1,155
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Exercise / conversion M · derivative	Stock Option (Right to Buy)	19,923	$0.00	$0	18,926
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Exercise / conversion M · derivative	Stock Option (Right to Buy)	30,568	$0.00	$0	11,606
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	385	$97.82	$37,661	32,768
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	668	$97.83	$65,347	33,153
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	19,255	$97.77	$1,882,561	33,821
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	30,568	$97.66	$2,985,375	53,076
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	1,648	$97.86	$161,273	83,644
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Exercise / conversion M	Ordinary Shares	385	$80.00	$30,800	85,292
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Exercise / conversion M	Ordinary Shares	19,923	$87.76	$1,748,442	84,907
2026-02-19	KIIL HARRY SKIP	EVP & President Cardiovascular	Exercise / conversion M	Ordinary Shares	30,568	$93.08	$2,845,269	64,984
2026-01-29	Blomquist Denise L.	Chief Accounting Officer	Other disposed transaction F	Ordinary Shares	148	$101.00	$14,948	12,306
2025-12-15	Wall Brett A.	EVP & Pres Neuroscience	Other disposed transaction F	Ordinary Shares	439	$99.87	$43,843	54,749
2025-12-05	KIIL HARRY SKIP	EVP & President Cardiovascular	Other disposed transaction F	Ordinary Shares	1,702	$101.36	$172,515	34,177
2025-11-20	Blomquist Denise L.	Chief Accounting Officer	Equity grant / award G	Ordinary Shares	170	$0.00	$0	12,357
2025-11-19	Smith Gregory L	EVP Global Ops & Supply Chain	Open-market sell S	Ordinary Shares	500	$102.08	$51,040	46,016
2025-11-19	Smith Gregory L	EVP Global Ops & Supply Chain	Open-market sell S	Ordinary Shares	325	$102.06	$33,170	46,516
2025-11-19	Smith Gregory L	EVP Global Ops & Supply Chain	Open-market sell S	Ordinary Shares	227	$102.05	$23,165	46,841
2025-11-19	Smith Gregory L	EVP Global Ops & Supply Chain	Open-market sell S	Ordinary Shares	825	$102.04	$84,183	47,068
2025-11-19	Smith Gregory L	EVP Global Ops & Supply Chain	Open-market sell S	Ordinary Shares	1,995	$102.03	$203,550	47,893
2025-11-19	Smith Gregory L	EVP Global Ops & Supply Chain	Open-market sell S	Ordinary Shares	1,942	$101.99	$198,065	49,888
2025-11-19	Smith Gregory L	EVP Global Ops & Supply Chain	Open-market sell S	Ordinary Shares	24,186	$101.93	$2,465,279	51,830
2025-09-03	KIIL HARRY SKIP	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	200	$91.59	$18,318	35,615
2025-09-03	KIIL HARRY SKIP	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	8,405	$91.58	$769,730	35,815
2025-08-25	Jellison William R	Dir	Open-market buy P	Ordinary Shares	2,500	$92.37	$230,925	5,000
2025-08-22	Jellison William R	Dir	Open-market buy P	Ordinary Shares	2,500	$92.73	$231,825	2,500
2025-08-20	Marinaro Michael	EVP, Pres MedSurg and Americas	Other disposed transaction F	Ordinary Shares	1,052	$93.22	$98,067	51,939
2025-08-01	Walter Matthew R.	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	963	$0.00	$0	0
2025-08-01	Walter Matthew R.	SVP, Chief HR Officer	Exercise / conversion M · derivative	Performance Share Unit	2,179	$0.00	$0	0
2025-08-01	Walter Matthew R.	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	879	$89.34	$78,530	31,857
2025-08-01	Walter Matthew R.	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	963	$78.00	$75,114	32,736
2025-08-01	Walter Matthew R.	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	364	$89.34	$32,520	31,773
2025-08-01	Walter Matthew R.	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	667	$89.34	$59,590	32,137
2025-08-01	Walter Matthew R.	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	2,179	$0.00	$0	32,804
2025-07-31	Smith Gregory L	EVP Global Ops & Supply Chain	Other disposed transaction F	Ordinary Shares	1,630	$90.24	$147,091	71,743
2025-07-28	Walter Matthew R.	SVP, Chief HR Officer	Equity grant / award A · derivative	Stock Option (Right to Buy)	30,669	$0.00	$0	30,669
2025-07-28	Walter Matthew R.	SVP, Chief HR Officer	Equity grant / award A · derivative	Performance Share Units	10,874	$0.00	$0	10,874
2025-07-28	Walter Matthew R.	SVP, Chief HR Officer	Equity grant / award A	Ordinary Shares	4,350	$0.00	$0	30,625
2025-06-03	Blomquist Denise L.	Chief Accounting Officer	Equity grant / award G	Ordinary Shares	310	$0.00	$0	10,143
2025-05-02	Walter Matthew R.	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	34	$84.85	$2,885	26,054
2025-04-28	Blomquist Denise L.	Chief Accounting Officer	Equity grant / award A	Ordinary Shares	2,975	$0.00	$0	10,453
2025-03-03	Marinaro Michael	EVP & President, Surgical OU	Other disposed transaction F	Ordinary Shares	575	$94.30	$54,222	40,675
2025-03-03	Pieton Thierry	EVP & Chief Financial Officer	Equity grant / award A · derivative	Stock Option (Right to Buy)	29,574	$0.00	$0	29,574
2025-03-03	Pieton Thierry	EVP & Chief Financial Officer	Equity grant / award A	Ordinary Shares	26,512	$0.00	$0	30,754
2025-03-03	Pieton Thierry	EVP & Chief Financial Officer	Equity grant / award A	Ordinary Shares	4,242	$0.00	$0	4,242
2025-01-27	Walter Matthew R.	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,337	$0.00	$0	0
2025-01-27	Walter Matthew R.	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	1,174	$92.46	$108,548	25,823
2025-01-27	Walter Matthew R.	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	1,337	$74.84	$100,061	26,997
2025-01-24	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M · derivative	Stock Option (Right to Buy)	12,437	$0.00	$0	0
2025-01-24	Wall Brett A.	EVP & Pres Neuroscience	Open-market sell S	Ordinary Shares	12,437	$90.00	$1,119,330	40,979
2025-01-24	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M	Ordinary Shares	12,437	$78.00	$970,086	53,416
2025-01-21	Corona Gary Louis	Interim CFO	Equity grant / award A	Ordinary Shares	11,315	$0.00	$0	44,255
2025-01-08	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M · derivative	Stock Option (Right to Buy)	6,850	$0.00	$0	0
2025-01-08	Wall Brett A.	EVP & Pres Neuroscience	Open-market sell S	Ordinary Shares	3,000	$80.41	$241,230	40,708
2025-01-08	Wall Brett A.	EVP & Pres Neuroscience	Open-market sell S	Ordinary Shares	6,850	$80.41	$550,808	43,708
2025-01-08	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M	Ordinary Shares	6,850	$74.84	$512,654	50,558
2024-12-16	Wall Brett A.	EVP & Pres Neuroscience	Other disposed transaction F	Ordinary Shares	645	$82.48	$53,200	43,708
2024-12-10	Fong Ivan K	EVP GENERAL COUNSEL & SECR	Other disposed transaction F	Ordinary Shares	3,009	$83.58	$251,492	55,224
2024-12-06	Kirk Jennifer M	Chief Accounting Officer	Other disposed transaction F	Ordinary Shares	646	$84.01	$54,270	28,011
2024-08-20	Marinaro Michael	EVP & President, Surgical OU	Other disposed transaction F	Ordinary Shares	2,045	$85.38	$174,602	40,346
2024-08-15	Corona Gary Louis	Interim CFO	Equity grant / award A	Ordinary Shares	8,966	$0.00	$0	33,035
2024-08-02	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M · derivative	Performance Share Units	5,311	$0.00	$0	0
2024-08-02	Wall Brett A.	EVP & Pres Neuroscience	Other disposed transaction F	Ordinary Shares	2,701	$81.51	$220,159	44,106
2024-08-02	Wall Brett A.	EVP & Pres Neuroscience	Other disposed transaction F	Ordinary Shares	2,362	$81.51	$192,527	46,807
2024-08-02	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M	Ordinary Shares	5,311	$0.00	$0	49,169
2024-07-31	Smith Gregory L	EVP Global Ops & Supply Chain	Other disposed transaction F	Ordinary Shares	1,406	$80.32	$112,930	61,267
2024-07-29	Walter Matthew R.	SVP, Chief HR Officer	Equity grant / award A · derivative	Stock Option (Right to Buy)	56,364	$0.00	$0	56,364
2024-07-29	Walter Matthew R.	SVP, Chief HR Officer	Equity grant / award A · derivative	Performance Share Unit	19,063	$0.00	$0	19,063
2024-07-29	Walter Matthew R.	SVP, Chief HR Officer	Equity grant / award A	Ordinary Shares	7,625	$0.00	$0	25,205
2024-07-18	Walter Matthew R.	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	492	$0.00	$0	0
2024-07-18	Walter Matthew R.	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	492	$62.76	$30,878	17,580
2024-06-07	Martha Geoffrey	Chairman and CEO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,594	$0.00	$0	0
2024-06-07	Martha Geoffrey	Chairman and CEO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	17,519	$0.00	$0	1,594
2024-06-07	Martha Geoffrey	Chairman and CEO	Open-market sell S	Ordinary Shares	1,594	$83.82	$133,609	143,348
2024-06-07	Martha Geoffrey	Chairman and CEO	Open-market sell S	Ordinary Shares	17,519	$83.76	$1,467,391	144,942
2024-06-07	Martha Geoffrey	Chairman and CEO	Exercise / conversion M	Ordinary Shares	1,594	$62.76	$100,039	162,461
2024-06-07	Martha Geoffrey	Chairman and CEO	Exercise / conversion M	Ordinary Shares	17,519	$62.76	$1,099,492	160,867
2024-05-01	Powell Kendall J	Dir	Other disposed transaction F	Ordinary Shares	192	$80.89	$15,531	45,843
2024-04-29	Powell Kendall J	Dir	Equity grant / award A	Ordinary Shares	2,165	$80.86	$175,062	46,035
2024-04-08	Marinaro Michael	EVP & President, Surgical OU	Open-market sell S	Ordinary Shares	854	$83.14	$71,002	27,925
2024-03-05	Marinaro Michael	EVP & President, Surgical OU	Other disposed transaction F	Ordinary Shares	563	$83.60	$47,067	28,779
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M · derivative	Stock Option (Right to Buy)	16,035	$0.00	$0	0
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M · derivative	Stock Option (Right to Buy)	13,066	$0.00	$0	0
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,594	$0.00	$0	13,066
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	16,035	$85.12	$1,364,899	48,289
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	13,066	$85.15	$1,112,570	64,324
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	1,594	$85.06	$135,586	77,390
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M	Ordinary Shares	16,035	$74.84	$1,200,059	78,984
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M	Ordinary Shares	13,066	$62.76	$820,022	62,949
2024-02-21	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M	Ordinary Shares	1,594	$62.76	$100,039	49,833
2024-02-01	Kirk Jennifer M	Chief Accounting Officer	Other disposed transaction F	Ordinary Shares	1,159	$88.09	$102,096	13,208
2023-12-19	Wall Brett A.	EVP & Pres Neuroscience	Open-market sell S	Ordinary Shares	4,997	$82.17	$410,603	28,910
2023-12-08	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Other disposed transaction F	Ordinary Shares	369	$79.27	$29,251	48,410
2023-10-30	Kirk Jennifer M	Chief Accounting Officer	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,695	$0.00	$0	1,695
2023-08-23	Smith Gregory L	EVP Global Ops & Supply Chain	Open-market sell S	Ordinary Shares	10,000	$83.84	$838,400	46,723
2023-08-14	Wall Brett A.	EVP & Pres Neuroscience	Open-market sell S	Ordinary Shares	1,000	$83.38	$83,380	33,573
2023-08-04	Marinaro Michael	EVP & President, Surgical OU	Open-market sell S	Ordinary Shares	1,352	$84.11	$113,717	28,930
2023-08-03	Marinaro Michael	EVP & President, Surgical OU	Exercise / conversion M · derivative	Performance Share Unit	1,696	$0.00	$0	0
2023-08-03	Marinaro Michael	EVP & President, Surgical OU	Other disposed transaction F	Ordinary Shares	1,323	$84.49	$111,780	30,282
2023-08-03	Marinaro Michael	EVP & President, Surgical OU	Equity grant / award A	Ordinary Shares	1,696	$0.00	$0	31,605
2023-07-31	Kirk Jennifer M	Chief Accounting Officer	Equity grant / award A · derivative	Stock Option (Right to Buy)	20,058	$0.00	$0	20,058
2023-07-31	Kirk Jennifer M	Chief Accounting Officer	Equity grant / award A · derivative	Performance Share Units	7,122	$0.00	$0	7,122
2023-07-31	Kirk Jennifer M	Chief Accounting Officer	Equity grant / award A	Ordinary Shares	2,849	$0.00	$0	13,376
2023-07-14	Wall Brett A.	EVP & Pres Neuroscience	Open-market sell S	Ordinary Shares	2,000	$87.97	$175,940	23,948
2023-07-10	TEN HOEDT ROB	EVP and Pres. Global Regions	Exercise / conversion M · derivative	Stock Option (Right to Buy)	3,706	$0.00	$0	0
2023-07-10	TEN HOEDT ROB	EVP and Pres. Global Regions	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,808	$0.00	$0	3,706
2023-07-10	TEN HOEDT ROB	EVP and Pres. Global Regions	Open-market sell S	Ordinary Shares	3,706	$86.58	$320,865	43,802
2023-07-10	TEN HOEDT ROB	EVP and Pres. Global Regions	Exercise / conversion M	Ordinary Shares	3,706	$55.32	$205,016	47,508
2023-07-10	TEN HOEDT ROB	EVP and Pres. Global Regions	Open-market sell S	Ordinary Shares	1,808	$86.59	$156,555	43,802
2023-07-10	TEN HOEDT ROB	EVP and Pres. Global Regions	Exercise / conversion M	Ordinary Shares	1,808	$55.32	$100,019	45,610
2023-05-02	OLEARY DENISE M	Dir	Other disposed transaction F	Ordinary Shares	169	$90.23	$15,249	73,838
2023-05-01	OLEARY DENISE M	Dir	Equity grant / award A	Ordinary Shares	1,930	$90.68	$175,012	74,007
2023-04-18	Smith Gregory L	EVP Global Ops & Supply Chain	Other disposed transaction F	Ordinary Shares	74	$80.71	$5,973	28,882
2023-04-05	Smith Gregory L	EVP Global Ops & Supply Chain	Other disposed transaction F	Ordinary Shares	6,866	$80.27	$551,134	28,579
2023-02-01	Kirk Jennifer M	Chief Accounting Officer	Other disposed transaction F	Ordinary Shares	672	$85.77	$57,637	10,115
2023-01-30	Medtronic plc	10%	Open-market buy P	Common Stock	6,835	$9.28	$63,436	4,999,423
2022-12-13	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M · derivative	Stock Option (Right to Buy)	14,823	$0.00	$0	0
2022-12-13	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,808	$0.00	$0	0
2022-12-13	Salmon Sean	EVP & President Cardiovascular	Open-market sell S	Ordinary Shares	16,631	$80.50	$1,338,736	36,088
2022-12-13	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M	Ordinary Shares	14,823	$55.32	$820,008	52,719
2022-12-13	Salmon Sean	EVP & President Cardiovascular	Exercise / conversion M	Ordinary Shares	1,808	$55.32	$100,019	37,896
2022-12-09	Fong Ivan K	EVP GENERAL COUNSEL & SECR	Other disposed transaction F	Ordinary Shares	5,206	$78.59	$409,140	32,830
2022-12-07	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Other disposed transaction F	Ordinary Shares	348	$79.04	$27,506	36,186
2022-10-14	TEN HOEDT ROB	EVP and Pres. Global Regions	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,404	$0.00	$0	0
2022-10-14	TEN HOEDT ROB	EVP and Pres. Global Regions	Open-market sell S	Ordinary Shares	2,404	$81.54	$196,015	43,483
2022-10-14	TEN HOEDT ROB	EVP and Pres. Global Regions	Exercise / conversion M	Ordinary Shares	2,404	$41.60	$100,006	45,887
2022-08-01	Smith Gregory L	EVP Global Ops & Supply Chain	Equity grant / award A · derivative	Stock Option (Right to Buy)	44,151	$0.00	$0	44,151
2022-08-01	Smith Gregory L	EVP Global Ops & Supply Chain	Equity grant / award A · derivative	Performance Share Units	13,967	$0.00	$0	13,967
2022-08-01	Smith Gregory L	EVP Global Ops & Supply Chain	Equity grant / award A	Ordinary Shares	5,587	$0.00	$0	34,783
2022-07-29	Wall Brett A.	EVP & Pres Neuroscience	Other disposed transaction D	Ordinary Shares	7,493	$0.00	$0	18,125
2022-05-03	Goldsmith Andrea Jo	Dir	Other disposed transaction F	Ordinary Shares	262	$103.11	$27,015	4,450
2022-05-02	Goldsmith Andrea Jo	Dir	Equity grant / award A	Ordinary Shares	1,697	$0.00	$0	4,712
2022-03-18	PARKHILL KAREN L	EVP & Chief Financial Officer	Open-market sell S	Ordinary Shares	682	$110.00	$75,020	34,946
2022-03-11	Surface Carol A	SVP, Chief HR Officer	Open-market sell S	Ordinary Shares	6,000	$105.30	$631,800	28,502
2022-02-01	Fong Ivan K	EVP GENERAL COUNSEL & SECR	Equity grant / award A · derivative	Performance Share Units	21,238	$0.00	$0	21,238
2022-02-01	Fong Ivan K	EVP GENERAL COUNSEL & SECR	Equity grant / award A · derivative	Stock Option (Right to Buy)	145,852	$103.59	$15,108,809	145,852
2022-02-01	Fong Ivan K	EVP GENERAL COUNSEL & SECR	Equity grant / award A · derivative	Performance Share Units	15,591	$0.00	$0	15,591
2022-02-01	Fong Ivan K	EVP GENERAL COUNSEL & SECR	Equity grant / award A · derivative	Stock Option (Right to Buy)	50,476	$103.59	$5,228,809	50,476
2022-02-01	Fong Ivan K	EVP GENERAL COUNSEL & SECR	Equity grant / award A	Ordinary Shares	24,134	$0.00	$0	30,371
2022-02-01	Fong Ivan K	EVP GENERAL COUNSEL & SECR	Equity grant / award A	Ordinary Shares	6,237	$0.00	$0	6,237
2021-12-23	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Open-market sell S	Ordinary Shares	7,218	$102.04	$736,525	39,430
2021-12-16	ANDERSON RICHARD H	Dir	Open-market buy P	Ordinary Shares	5,010	$103.26	$517,333	108,374
2021-12-15	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Other disposed transaction F	Ordinary Shares	89	$104.94	$9,340	33,083
2021-12-06	PARKHILL KAREN L	EVP & Chief Financial Officer	Open-market sell S	Ordinary Shares	682	$110.00	$75,020	35,446
2021-12-06	PARKHILL KAREN L	EVP & Chief Financial Officer	Equity grant / award G	Ordinary Shares	49,859	$0.00	$0	49,859
2021-11-05	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Other disposed transaction F	Ordinary Shares	246	$122.98	$30,253	46,648
2021-11-01	TEN HOEDT ROB	EVP & President EMEA	Equity grant / award A · derivative	Performance Share Units	2,080	$0.00	$0	2,080
2021-11-01	TEN HOEDT ROB	EVP & President EMEA	Equity grant / award A · derivative	Stock Option (Right to Buy)	6,670	$0.00	$0	6,670
2021-11-01	TEN HOEDT ROB	EVP & President EMEA	Equity grant / award A	Ordinary Shares	832	$0.00	$0	45,418
2021-10-08	PARKHILL KAREN L	EVP & Chief Financial Officer	Equity grant / award G	Ordinary Shares	12,000	$0.00	$0	49,859
2021-10-06	PARKHILL KAREN L	EVP & Chief Financial Officer	Equity grant / award G	Ordinary Shares	37,859	$0.00	$0	37,859
2021-09-30	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M · derivative	Stock Option (Right to Buy)	49,147	$0.00	$0	0
2021-09-30	Lerman Bradley E	SVP General Counsel & Corp Sec	Open-market sell S	Ordinary Shares	49,147	$126.58	$6,221,027	48,763
2021-09-30	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M	Ordinary Shares	49,147	$78.00	$3,833,466	97,910
2021-08-31	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M · derivative	Stock Option (Right to Buy)	50,775	$0.00	$0	0
2021-08-31	Lerman Bradley E	SVP General Counsel & Corp Sec	Open-market sell S	Ordinary Shares	50,775	$134.17	$6,812,482	48,763
2021-08-31	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M	Ordinary Shares	50,775	$74.84	$3,800,001	99,538
2021-08-25	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	4,713	$0.00	$0	0
2021-08-25	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,577	$0.00	$0	0
2021-08-25	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	21,129	$0.00	$0	0
2021-08-25	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Open-market sell S	Ordinary Shares	7,290	$134.09	$977,516	33,329
2021-08-25	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Exercise / conversion M	Ordinary Shares	4,713	$38.20	$180,037	40,619
2021-08-25	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Exercise / conversion M	Ordinary Shares	2,577	$38.81	$100,013	35,906
2021-08-25	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Open-market sell S	Ordinary Shares	21,129	$134.08	$2,832,976	33,329
2021-08-25	Salmon Sean	EVP & Pres Diabetes/Cardiovasc	Exercise / conversion M	Ordinary Shares	21,129	$38.81	$820,016	54,458
2021-08-02	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Equity grant / award A · derivative	Performance Share Units	15,237	$0.00	$0	15,237
2021-08-02	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,085	$0.00	$0	1,085
2021-08-02	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Equity grant / award A · derivative	Stock Option (Right to Buy)	52,074	$0.00	$0	52,074
2021-08-02	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Equity grant / award A	Ordinary Shares	6,095	$0.00	$0	46,769
2021-08-02	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Other disposed transaction F	Ordinary Shares	4,897	$131.31	$643,025	40,674
2021-06-28	Martha Geoffrey	CEO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	11,500	$0.00	$0	1,481
2021-06-28	Martha Geoffrey	CEO	Open-market sell S	Ordinary Shares	11,500	$125.29	$1,440,835	81,948
2021-06-28	Martha Geoffrey	CEO	Exercise / conversion M	Ordinary Shares	11,500	$55.32	$636,180	93,448
2021-06-22	PARKHILL KAREN L	EVP & Chief Financial Officer	Equity grant / award G	Ordinary Shares	238	$0.00	$0	843
2021-06-21	Wall Brett A.	EVP & Pres Neuroscience	Open-market sell S	Ordinary Shares	115	$123.50	$14,202	21,602
2021-06-18	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,168	$0.00	$0	6,850
2021-06-18	Wall Brett A.	EVP & Pres Neuroscience	Other disposed transaction F	Ordinary Shares	938	$123.23	$115,590	21,717
2021-06-18	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M	Ordinary Shares	1,168	$74.84	$87,413	22,655
2021-06-15	PARKHILL KAREN L	EVP & Chief Financial Officer	Open-market sell S	Ordinary Shares	605	$124.47	$75,304	86,223
2021-06-01	Wall Brett A.	EVP & Pres Neuroscience	Open-market sell S	Ordinary Shares	2,473	$128.07	$316,717	21,487
2021-05-28	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M · derivative	Stock Option (Right to Buy)	12,300	$0.00	$0	0
2021-05-28	Wall Brett A.	EVP & Pres Neuroscience	Other disposed transaction F	Ordinary Shares	7,355	$126.59	$931,069	23,960
2021-05-28	Wall Brett A.	EVP & Pres Neuroscience	Exercise / conversion M	Ordinary Shares	12,300	$47.00	$578,100	31,315
2021-05-03	Powell Kendall J	Dir	Equity grant / award A	Ordinary Shares	1,334	$0.00	$0	35,466
2021-04-27	ANDERSON RICHARD H	Dir	Other disposed transaction F	Ordinary Shares	426	$129.97	$55,367	101,716
2021-04-05	Martha Geoffrey	CEO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	9,308	$0.00	$0	11,173
2021-04-05	Martha Geoffrey	CEO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,404	$0.00	$0	0
2021-04-05	Martha Geoffrey	CEO	Open-market sell S	Ordinary Shares	9,308	$118.83	$1,106,070	81,938
2021-04-05	Martha Geoffrey	CEO	Exercise / conversion M	Ordinary Shares	9,308	$55.32	$514,919	91,246
2021-04-05	Martha Geoffrey	CEO	Open-market sell S	Ordinary Shares	2,404	$118.83	$285,667	81,938
2021-04-05	Martha Geoffrey	CEO	Exercise / conversion M	Ordinary Shares	2,404	$41.60	$100,006	84,342
2021-03-15	PARKHILL KAREN L	EVP & Chief Financial Officer	Open-market sell S	Ordinary Shares	632	$119.12	$75,284	86,556
2021-03-02	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M · derivative	Stock Option (Right to Buy)	7,168	$0.00	$0	0
2021-03-02	TEN HOEDT ROB	EVP & President EMEA	Open-market sell S	Ordinary Shares	7,168	$117.98	$845,681	43,797
2021-03-02	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M	Ordinary Shares	7,168	$34.88	$250,020	50,965
2021-02-01	Salmon Sean	EVP & Group President Diabetes	Equity grant / award A · derivative	Performance Share Units	4,947	$0.00	$0	4,947
2021-02-01	Salmon Sean	EVP & Group President Diabetes	Equity grant / award A · derivative	Stock Option (Right to Buy)	16,314	$0.00	$0	16,314
2021-02-01	Salmon Sean	EVP & Group President Diabetes	Equity grant / award A	Ordinary Shares	1,979	$0.00	$0	30,007
2020-12-28	Surface Carol A	SVP, Chief HR Officer	Open-market sell S	Ordinary Shares	15,000	$114.90	$1,723,500	34,150
2020-12-22	Lerman Bradley E	SVP General Counsel & Corp Sec	Open-market sell S	Ordinary Shares	2,605	$115.56	$301,034	51,543
2020-12-18	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Open-market sell S	Ordinary Shares	10,930	$115.46	$1,261,978	44,922
2020-12-16	WHITE ROBERT JOHN	EVP & Pres. Medical Surgical	Equity grant / award G	Ordinary Shares	1,500	$0.00	$0	1,500
2020-12-15	PARKHILL KAREN L	EVP & Chief Financial Officer	Open-market sell S	Ordinary Shares	670	$114.33	$76,601	86,897
2020-11-09	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M · derivative	Stock Option (Right to Buy)	797	$0.00	$0	0
2020-11-09	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M · derivative	Stock Option (Right to Buy)	19,918	$0.00	$0	0
2020-11-09	Lerman Bradley E	SVP General Counsel & Corp Sec	Open-market sell S	Ordinary Shares	20,715	$113.13	$2,343,488	54,148
2020-11-09	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M	Ordinary Shares	797	$62.76	$50,020	74,863
2020-11-09	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M	Ordinary Shares	19,918	$62.76	$1,250,054	74,066
2020-11-03	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction F	Ordinary Shares	299	$103.13	$30,836	57,352
2020-10-15	ISHRAK OMAR	Executive Chairman	Equity grant / award G	Ordinary Shares	8,650	$0.00	$0	8,650
2020-10-14	HOGAN RANDALL J	Dir	Equity grant / award G	Ordinary Shares	36,798	$0.00	$0	36,798
2020-10-09	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A · derivative	Performance Share Units	16,563	$0.00	$0	16,563
2020-10-08	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M · derivative	Stock Option (Right to Buy)	797	$0.00	$0	797
2020-10-08	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M · derivative	Stock Option (Right to Buy)	19,917	$0.00	$0	19,918
2020-10-08	Lerman Bradley E	SVP General Counsel & Corp Sec	Open-market sell S	Ordinary Shares	797	$110.00	$87,670	54,325
2020-10-08	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M	Ordinary Shares	797	$62.76	$50,020	55,122
2020-10-08	Lerman Bradley E	SVP General Counsel & Corp Sec	Open-market sell S	Ordinary Shares	19,917	$110.00	$2,190,870	54,325
2020-10-08	Lerman Bradley E	SVP General Counsel & Corp Sec	Exercise / conversion M	Ordinary Shares	19,917	$62.76	$1,249,991	74,242
2020-09-23	TEN HOEDT ROB	EVP & President EMEA	Open-market sell S	Ordinary Shares	9,584	$104.34	$999,995	43,476
2020-09-15	PARKHILL KAREN L	EVP & Chief Financial Officer	Open-market sell S	Ordinary Shares	702	$107.78	$75,662	87,366
2020-09-09	TEN HOEDT ROB	EVP & President EMEA	Open-market sell S	Ordinary Shares	9,563	$105.05	$1,004,593	53,060
2020-08-03	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A · derivative	Stock Option (Right to Buy)	40,302	$0.00	$0	40,302
2020-08-03	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,575	$0.00	$0	1,575
2020-08-03	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A · derivative	Stock Option (Right to Buy)	68,010	$0.00	$0	68,010
2020-08-03	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A	Ordinary Shares	7,398	$0.00	$0	57,492
2020-07-31	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction F	Ordinary Shares	2,727	$96.48	$263,101	50,094
2020-06-30	ISHRAK OMAR	Executive Chairman	Equity grant / award G	Ordinary Shares	22,508	$0.00	$0	22,508
2020-06-01	PARKHILL KAREN L	EVP & Chief Financial Officer	Equity grant / award G	Ordinary Shares	305	$0.00	$0	605
2020-05-29	Surface Carol A	SVP, Chief HR Officer	Open-market sell S	Ordinary Shares	2,000	$97.72	$195,440	47,443
2020-04-29	Powell Kendall J	Dir	Other disposed transaction F	Ordinary Shares	393	$99.14	$38,962	34,064
2020-04-27	Powell Kendall J	Dir	Equity grant / award A	Ordinary Shares	1,737	$0.00	$0	34,457
2020-04-03	OLEARY DENISE M	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,813	$0.00	$0	0
2020-04-03	OLEARY DENISE M	Dir	Other disposed transaction F	Ordinary Shares	929	$86.27	$80,145	65,615
2020-04-03	OLEARY DENISE M	Dir	Exercise / conversion M	Ordinary Shares	1,813	$44.13	$80,008	66,544
2020-02-20	ISHRAK OMAR	Chairman & CEO	Open-market buy P	Ordinary Shares	8,771	$113.68	$997,087	605,190
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Exercise / conversion M · derivative	Stock Option (Right to Buy)	38,558	$0.00	$0	0
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,808	$0.00	$0	0
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,404	$0.00	$0	0
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	38,558	$113.56	$4,378,646	71,013
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Exercise / conversion M	Ordinary Shares	38,558	$55.32	$2,133,029	109,571
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	1,808	$113.66	$205,497	71,013
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Exercise / conversion M	Ordinary Shares	1,808	$55.32	$100,019	72,821
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	2,404	$113.60	$273,094	71,013
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Exercise / conversion M	Ordinary Shares	2,404	$41.60	$100,006	73,417
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	3,019	$113.63	$343,049	71,013
2019-12-24	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	5,067	$113.64	$575,814	74,032
2019-12-18	Lerman Bradley E	SVP General Counsel & Corp Sec	Equity grant / award G	Ordinary Shares	2,275	$0.00	$0	50,802
2019-12-06	ANDERSON RICHARD H	Dir	Open-market buy P	Ordinary Shares	5,000	$113.29	$566,450	95,231
2019-12-03	ISHRAK OMAR	Chairman & CEO	Equity grant / award G	Ordinary Shares	18,182	$0.00	$0	18,182
2019-12-02	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	26,724	$0.00	$0	0
2019-12-02	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	25,442	$0.00	$0	0
2019-12-02	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	12,583	$110.97	$1,396,373	52,068
2019-12-02	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	12,859	$110.28	$1,418,091	64,651
2019-12-02	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	13,240	$110.97	$1,469,283	77,510
2019-12-02	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	13,484	$110.28	$1,487,083	90,750
2019-12-02	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M	Ordinary Shares	26,724	$74.84	$2,000,024	104,234
2019-12-02	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M	Ordinary Shares	25,442	$47.00	$1,195,774	77,510
2019-11-15	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	36,874	$0.00	$0	0
2019-11-15	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Open-market sell S	Ordinary Shares	3,797	$112.07	$425,530	188,262
2019-11-15	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Open-market sell S	Ordinary Shares	25,710	$111.31	$2,861,883	192,059
2019-11-15	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Open-market sell S	Ordinary Shares	7,367	$110.58	$814,680	217,769
2019-11-15	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M	Ordinary Shares	36,874	$38.81	$1,431,080	225,136
2019-11-14	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,202	$0.00	$0	0
2019-11-14	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	900	$0.00	$0	36,874
2019-11-14	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Open-market sell S	Ordinary Shares	1,202	$109.95	$132,160	188,262
2019-11-14	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M	Ordinary Shares	1,202	$41.60	$50,003	189,464
2019-11-14	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Open-market sell S	Ordinary Shares	900	$109.52	$98,571	188,262
2019-11-14	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M	Ordinary Shares	900	$38.81	$34,929	189,162
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	5,313	$0.00	$0	25,442
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	37,209	$0.00	$0	0
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	9,643	$0.00	$0	0
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	1,964	$109.66	$215,378	52,068
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	3,349	$109.11	$365,419	54,032
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M	Ordinary Shares	5,313	$47.00	$249,711	57,381
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	14,662	$109.67	$1,607,938	52,068
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	28,428	$109.11	$3,101,722	66,730
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M	Ordinary Shares	37,209	$36.58	$1,361,105	95,158
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Open-market sell S	Ordinary Shares	3,762	$109.66	$412,537	57,949
2019-11-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M	Ordinary Shares	9,643	$29.52	$284,661	61,711
2019-10-28	Martha Geoffrey	EVP & GroupPres Restora Therap	Equity grant / award A · derivative	Stock Option (Right to Buy)	65,170	$106.22	$6,922,357	65,170
2019-10-28	Martha Geoffrey	EVP & GroupPres Restora Therap	Equity grant / award A	Ordinary Shares	9,729	$0.00	$0	61,536
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	17,466	$0.00	$0	17,468
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	24,983	$0.00	$0	8,328
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	34,189	$0.00	$0	1,283
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	7,569	$0.00	$0	399
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	72,848	$107.58	$7,836,988	49,072
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	17,466	$83.97	$1,466,620	121,920
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	24,983	$88.06	$2,200,003	104,454
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	34,189	$78.00	$2,666,742	79,471
2019-10-11	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	7,569	$62.76	$475,030	45,282
2019-10-07	ISHRAK OMAR	Chairman & CEO	Equity grant / award G	Ordinary Shares	4,100	$0.00	$0	602,808
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	7,995	$0.00	$0	0
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	27,353	$0.00	$0	9,643
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	16,817	$0.00	$0	0
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction D	Ordinary Shares	2,300	$109.37	$251,542	51,917
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction D	Ordinary Shares	14,517	$108.40	$1,573,701	54,217
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction D	Ordinary Shares	1,050	$109.35	$114,820	68,734
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction D	Ordinary Shares	6,945	$108.42	$752,949	69,784
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction D	Ordinary Shares	3,800	$109.35	$415,534	76,729
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction D	Ordinary Shares	23,553	$108.40	$2,553,239	80,529
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M	Ordinary Shares	7,995	$25.41	$203,153	104,082
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M	Ordinary Shares	27,353	$29.52	$807,461	96,087
2019-10-01	WHITE ROBERT JOHN	EVP & President MITG	Exercise / conversion M	Ordinary Shares	16,817	$27.29	$458,936	68,734
2019-09-27	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	100	$108.21	$10,821	78,816
2019-09-27	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	21,325	$107.51	$2,292,672	78,916
2019-09-25	Lenehan James T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,813	$0.00	$0	0
2019-09-25	Lenehan James T	Dir	Other disposed transaction F	Ordinary Shares	744	$107.62	$80,069	54,720
2019-09-25	Lenehan James T	Dir	Exercise / conversion M	Ordinary Shares	1,813	$44.13	$80,008	55,464
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	423	$0.00	$0	1,272
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	14,121	$0.00	$0	42,364
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	595	$0.00	$0	596
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	19,054	$0.00	$0	19,055
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	852	$0.00	$0	284
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	27,254	$0.00	$0	9,085
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	321	$0.00	$0	0
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	10,257	$0.00	$0	321
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	423	$107.22	$45,354	30,761
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	423	$89.08	$37,681	31,184
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	14,121	$107.41	$1,516,765	30,761
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	14,121	$89.08	$1,257,899	44,882
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	595	$107.22	$63,796	30,761
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	595	$83.97	$49,962	31,356
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	19,054	$107.41	$2,046,666	30,761
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	19,054	$83.97	$1,599,964	49,815
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	852	$107.22	$91,351	30,761
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	852	$88.06	$75,027	31,613
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	27,254	$107.28	$2,923,864	30,761
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	27,254	$88.06	$2,399,987	58,015
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	321	$107.22	$34,418	30,761
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	321	$78.00	$25,038	31,082
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	10,257	$107.31	$1,100,648	30,761
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	10,257	$78.00	$800,046	41,018
2019-09-10	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	10,000	$107.08	$1,070,850	30,761
2019-08-05	Lerman Bradley E	SVP General Counsel & Corp Sec	Open-market sell S	Ordinary Shares	4,000	$100.31	$401,240	52,906
2019-08-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction F	Ordinary Shares	5,336	$102.37	$546,246	51,917
2019-08-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction F	Ordinary Shares	2,846	$102.37	$291,345	57,253
2019-07-29	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,615	$0.00	$0	1,615
2019-07-29	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A · derivative	Stock Option (Right to Buy)	77,514	$0.00	$0	77,514
2019-07-29	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A	Ordinary Shares	11,622	$0.00	$0	60,099
2019-07-22	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	3,438	$101.12	$347,651	100,127
2019-06-21	PARKHILL KAREN L	EVP & Chief Financial Officer	Equity grant / award G	Ordinary Shares	300	$0.00	$0	300
2019-06-21	PARKHILL KAREN L	EVP & Chief Financial Officer	Equity grant / award G	Ordinary Shares	900	$0.00	$0	76,507
2019-06-20	PARKHILL KAREN L	EVP & Chief Financial Officer	Other disposed transaction F	Ordinary Shares	6,945	$99.26	$689,361	77,407
2019-06-17	Surface Carol A	SVP, Chief HR Officer	Open-market sell S	Ordinary Shares	9,000	$97.66	$878,976	34,158
2019-06-12	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	31,731	$0.00	$0	10,578
2019-06-12	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	20,933	$97.49	$2,040,758	42,673
2019-06-12	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	31,731	$97.49	$3,093,455	63,606
2019-06-12	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	31,731	$78.00	$2,475,018	95,337
2019-06-06	Martha Geoffrey	EVP & GroupPres Restora Therap	Open-market sell S	Ordinary Shares	11,000	$96.05	$1,056,583	48,918
2019-05-28	TEN HOEDT ROB	EVP & President EMEA	Open-market sell S	Ordinary Shares	9,000	$91.88	$826,920	58,785
2019-05-28	TEN HOEDT ROB	EVP & President EMEA	Open-market sell S	Ordinary Shares	9,000	$91.88	$826,920	58,785
2019-05-24	ANDERSON RICHARD H	Dir	Open-market buy P	Ordinary Shares	10,900	$92.40	$1,007,160	89,912
2019-04-30	Powell Kendall J	Dir	Other disposed transaction F	Ordinary Shares	537	$88.81	$47,691	32,247
2019-04-30	Powell Kendall J	Dir	Other disposed transaction F	Ordinary Shares	537	$88.81	$47,691	32,247
2019-04-29	Powell Kendall J	Dir	Equity grant / award A	Ordinary Shares	2,002	$0.00	$0	32,784
2019-04-29	Powell Kendall J	Dir	Equity grant / award A	Ordinary Shares	2,002	$0.00	$0	32,784
2019-04-01	OLEARY DENISE M	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,671	$0.00	$0	0
2019-04-01	OLEARY DENISE M	Dir	Exercise / conversion M	Ordinary Shares	2,671	$29.96	$80,023	62,484
2019-03-20	Kuntz Richard	SVP & Chief Medical & Science	Equity grant / award G	Ordinary Shares	2,778	$0.00	$0	103,241
2019-03-20	Kuntz Richard	SVP & Chief Medical & Science	Equity grant / award G	Ordinary Shares	2,778	$0.00	$0	103,241
2019-03-04	Lenehan James T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,671	$0.00	$0	0
2019-03-04	Lenehan James T	Dir	Exercise / conversion M	Ordinary Shares	2,671	$29.96	$80,023	51,808
2019-01-09	PARKHILL KAREN L	EVP & Chief Financial Officer	Open-market buy P	Ordinary Shares	3,000	$83.87	$251,610	83,680
2018-12-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction F	Ordinary Shares	1,698	$97.53	$165,606	47,590
2018-10-29	Liddicoat John R	EVP & President of Americas	Equity grant / award A · derivative	Stock Option (Right to Buy)	17,157	$0.00	$0	17,157
2018-10-29	Liddicoat John R	EVP & President of Americas	Equity grant / award A	Ordinary Shares	2,982	$0.00	$0	42,043
2018-09-24	Martha Geoffrey	EVP & GroupPres Restora Therap	Exercise / conversion M · derivative	Stock Option (Right to Buy)	21,129	$0.00	$0	0
2018-09-24	Martha Geoffrey	EVP & GroupPres Restora Therap	Exercise / conversion M · derivative	Stock Option (Right to Buy)	28,670	$0.00	$0	0
2018-09-24	Martha Geoffrey	EVP & GroupPres Restora Therap	Open-market sell S	Ordinary Shares	49,799	$97.93	$4,876,667	59,202
2018-09-24	Martha Geoffrey	EVP & GroupPres Restora Therap	Exercise / conversion M	Ordinary Shares	21,129	$38.81	$820,016	109,001
2018-09-24	Martha Geoffrey	EVP & GroupPres Restora Therap	Exercise / conversion M	Ordinary Shares	28,670	$34.88	$1,000,010	87,872
2018-09-14	ISHRAK OMAR	Chairman & CEO	Equity grant / award G	Ordinary Shares	10,000	$0.00	$0	10,000
2018-09-07	ISHRAK OMAR	Chairman & CEO	Equity grant / award G	Ordinary Shares	4,580	$0.00	$0	566,396
2018-08-31	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	18,324	$0.00	$0	0
2018-08-31	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	7,436	$0.00	$0	0
2018-08-31	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	399	$0.00	$0	0
2018-08-31	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	26,159	$96.29	$2,518,798	62,647
2018-08-31	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	18,324	$62.76	$1,150,014	88,806
2018-08-31	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	7,436	$62.76	$466,683	70,482
2018-08-31	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	399	$62.76	$25,041	63,046
2018-08-28	Kuntz Richard	SVP & Chief Medical & Science	Exercise / conversion M · derivative	Stock Option (Right to Buy)	41,227	$0.00	$0	0
2018-08-28	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	47,176	$95.88	$4,523,089	105,403
2018-08-28	Kuntz Richard	SVP & Chief Medical & Science	Exercise / conversion M	Ordinary Shares	41,227	$38.81	$1,600,020	152,579
2018-08-23	POZEN ROBERT C	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,813	$0.00	$0	0
2018-08-23	POZEN ROBERT C	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,671	$0.00	$0	0
2018-08-23	POZEN ROBERT C	Dir	Open-market sell S	Ordinary Shares	3,218	$95.94	$308,738	60,964
2018-08-23	POZEN ROBERT C	Dir	Exercise / conversion M	Ordinary Shares	1,813	$44.13	$80,008	64,182
2018-08-23	POZEN ROBERT C	Dir	Exercise / conversion M	Ordinary Shares	2,671	$29.96	$80,023	62,369
2018-08-22	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	84,060	$0.00	$0	0
2018-08-22	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	70,984	$0.00	$0	0
2018-08-22	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M · derivative	Stock Option (Right to Buy)	23,175	$0.00	$0	0
2018-08-22	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Open-market sell S	Ordinary Shares	145,544	$95.50	$13,899,161	200,180
2018-08-22	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M	Ordinary Shares	84,060	$34.88	$2,932,013	345,724
2018-08-22	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M	Ordinary Shares	70,984	$37.53	$2,664,030	261,664
2018-08-22	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Exercise / conversion M	Ordinary Shares	23,175	$43.15	$1,000,001	190,680
2018-08-03	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction F	Ordinary Shares	2,806	$90.48	$253,887	49,074
2018-08-01	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction F	Ordinary Shares	207	$90.24	$18,680	51,879
2018-07-30	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,695	$0.00	$0	1,695
2018-07-30	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A · derivative	Stock Option (Right to Buy)	63,263	$0.00	$0	63,263
2018-07-30	WHITE ROBERT JOHN	EVP & President MITG	Equity grant / award A	Ordinary Shares	10,478	$0.00	$0	52,086
2018-07-28	HAKAMI HOOMAN	EVP & Group President Diabetes	Other disposed transaction F	Ordinary Shares	9,042	$88.66	$801,664	58,113
2018-07-28	HAKAMI HOOMAN	EVP & Group President Diabetes	Other disposed transaction F	Ordinary Shares	10,038	$88.66	$889,969	57,117
2018-06-22	Surface Carol A	SVP, Chief HR Officer	Other acquired transaction I	Ordinary Shares	265	$86.81	$23,005	532
2018-06-22	Surface Carol A	SVP, Chief HR Officer	Other acquired transaction I	Ordinary Shares	720	$86.81	$62,503	1,560
2018-06-20	PARKHILL KAREN L	EVP & Chief Financial Officer	Other disposed transaction F	Ordinary Shares	6,527	$86.13	$562,171	66,039
2018-06-12	POZEN ROBERT C	Dir	Equity grant / award G	Ordinary Shares	11,625	$0.00	$0	59,543
2018-06-11	Lerman Bradley E	SVP General Counsel & Corp Sec	Open-market sell S	Ordinary Shares	8,910	$86.82	$773,566	51,842
2018-06-08	Kuntz Richard	SVP & Chief Medical & Science	Open-market sell S	Ordinary Shares	11,500	$87.13	$1,001,995	105,923
2018-05-07	MEDTRONIC INC	10%	Exercise / conversion C · derivative	Series F Convertible Preferred Stock	425,539	$0.00	$0	0
2018-05-07	MEDTRONIC INC	10%	Exercise / conversion C · derivative	Series D Convertible Preferred Stock	697,816	$0.00	$0	0
2018-05-07	MEDTRONIC INC	10%	Exercise / conversion C · derivative	Series C Convertible Preferred Stock	1,261,949	$0.00	$0	0
2018-05-07	MEDTRONIC INC	10%	Exercise / conversion C	Common Stock	63,990	—	—	767,856
2018-05-07	MEDTRONIC INC	10%	Exercise / conversion C	Common Stock	104,934	—	—	703,866
2018-05-07	MEDTRONIC INC	10%	Exercise / conversion C	Common Stock	189,766	—	—	598,932
2018-05-01	Lenehan James T	Dir	Other disposed transaction F	Ordinary Shares	616	$81.01	$49,902	48,734
2018-04-30	Lenehan James T	Dir	Equity grant / award A	Ordinary Shares	2,184	$0.00	$0	49,350
2018-04-17	OLEARY DENISE M	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,590	$0.00	$0	0
2018-04-17	OLEARY DENISE M	Dir	Exercise / conversion M	Ordinary Shares	1,590	$50.34	$80,041	57,698
2018-03-13	Lenehan James T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,590	$0.00	$0	0
2018-03-13	Lenehan James T	Dir	Open-market sell S	Ordinary Shares	1,306	$83.56	$109,123	47,028
2018-03-13	Lenehan James T	Dir	Exercise / conversion M	Ordinary Shares	1,590	$50.34	$80,041	48,334
2018-03-05	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,195	$0.00	$0	6,374
2018-03-05	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	22,706	$0.00	$0	7,569
2018-03-05	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M · derivative	Stock Option (Right to Buy)	24,719	$0.00	$0	8,239
2018-03-05	Surface Carol A	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	40,338	$79.74	$3,216,552	37,813
2018-03-05	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	1,195	$62.76	$74,998	78,151
2018-03-05	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	22,706	$62.76	$1,425,029	76,956
2018-03-05	Surface Carol A	SVP, Chief HR Officer	Exercise / conversion M	Ordinary Shares	24,719	$57.65	$1,425,050	54,250
2018-03-05	Surface Carol A	SVP, Chief HR Officer	Open-market sell S	Ordinary Shares	12,479	$78.36	$977,854	29,531
2018-03-02	Surface Carol A	SVP, Chief HR Officer	Open-market sell S	Ordinary Shares	12,000	$78.00	$936,000	42,010
2018-02-18	WHITE ROBERT JOHN	EVP & President MITG	Other disposed transaction F	Ordinary Shares	1,472	$83.31	$122,632	40,890
2018-01-09	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M · derivative	Stock Option (Right to Buy)	45,872	$0.00	$0	0
2018-01-09	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M · derivative	Stock Option (Right to Buy)	35,492	$0.00	$0	0
2018-01-09	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Open-market sell S	Ordinary Shares	78,526	$86.21	$6,769,726	117,107
2018-01-09	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M	Ordinary Shares	45,872	$34.88	$1,600,015	195,633
2018-01-09	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M	Ordinary Shares	35,492	$37.53	$1,332,015	149,761
2018-01-05	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M · derivative	Stock Option (Right to Buy)	26,158	$0.00	$0	26,159
2018-01-05	HAKAMI HOOMAN	EVP & Group President Diabetes	Open-market sell S	Ordinary Shares	26,158	$85.00	$2,223,430	65,828
2018-01-05	HAKAMI HOOMAN	EVP & Group President Diabetes	Exercise / conversion M	Ordinary Shares	26,158	$62.76	$1,641,676	91,986
2017-12-15	Hanson Bryan C	EVP, President, MITG	Open-market sell S	Ordinary Shares	16,000	$82.82	$1,325,120	88,818
2017-12-01	Hanson Bryan C	EVP, President, MITG	Other disposed transaction F	Ordinary Shares	4,249	$81.27	$345,316	104,818
2017-11-16	Hanson Bryan C	EVP, President, MITG	Open-market sell S	Ordinary Shares	16,000	$79.02	$1,264,320	109,067
2017-10-28	Surface Carol A	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	8,602	$81.30	$699,343	53,871
2017-10-16	Hanson Bryan C	EVP, President, MITG	Open-market sell S	Ordinary Shares	16,000	$78.03	$1,248,480	124,555
2017-09-15	ISHRAK OMAR	Chairman & CEO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	100,000	$0.00	$0	115,338
2017-09-15	ISHRAK OMAR	Chairman & CEO	Open-market sell S	Ordinary Shares	140,407	$81.63	$11,461,423	528,096
2017-09-15	ISHRAK OMAR	Chairman & CEO	Exercise / conversion M	Ordinary Shares	100,000	$38.81	$3,881,000	668,503
2017-08-25	OLEARY DENISE M	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,010	$0.00	$0	0
2017-08-25	OLEARY DENISE M	Dir	Exercise / conversion M	Ordinary Shares	1,010	$52.84	$53,368	55,560
2017-08-23	ISHRAK OMAR	Chairman & CEO	Equity grant / award G	Ordinary Shares	12,195	$0.00	$0	12,195
2017-07-31	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,191	$0.00	$0	1,191
2017-07-31	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Equity grant / award A · derivative	Stock Option (Right to Buy)	41,285	$0.00	$0	41,285
2017-07-31	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Equity grant / award A	Ordinary Shares	10,322	$0.00	$0	113,945
2017-07-28	COYLE MICHAEL J	EVP & Group Pres, Cardiac&Vasc	Other disposed transaction F	Ordinary Shares	7,270	$84.29	$612,788	140,193
2017-07-17	Hanson Bryan C	EVP, President, MITG	Open-market sell S	Ordinary Shares	12,000	$88.57	$1,062,840	136,912
2017-07-10	Lenehan James T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,010	$0.00	$0	0
2017-07-10	Lenehan James T	Dir	Exercise / conversion M	Ordinary Shares	1,010	$52.84	$53,368	46,353
2017-06-21	ANDERSON RICHARD H	Dir	Open-market buy P	Ordinary Shares	5,600	$88.90	$497,840	71,910
2017-06-20	PARKHILL KAREN L	EVP & Chief Financial Officer	Other disposed transaction F	Ordinary Shares	7,047	$88.82	$625,915	57,781
2017-06-14	POZEN ROBERT C	Dir	Other disposed transaction F	Ordinary Shares	628	$87.65	$55,044	68,987
2017-05-26	Lenehan James T	Dir	Other disposed transaction F	Ordinary Shares	647	$85.09	$55,053	45,343
2017-05-02	HOGAN RANDALL J	Dir	Other disposed transaction F	Ordinary Shares	650	$84.75	$55,088	33,911
2017-05-01	ANDERSON RICHARD H	Dir	Equity grant / award A	Ordinary Shares	2,090	$0.00	$0	66,959
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M · derivative	Stock Option (Right to Buy)	11,117	$0.00	$0	5,514
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M · derivative	Stock Option (Right to Buy)	10,357	$0.00	$0	11,951
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M · derivative	Stock Option (Right to Buy)	21,129	$0.00	$0	0
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M · derivative	Stock Option (Right to Buy)	8,154	$0.00	$0	0
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Open-market sell S	Ordinary Shares	50,757	$81.58	$4,140,594	51,238
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M	Ordinary Shares	11,117	$55.32	$614,992	101,995
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M	Ordinary Shares	10,357	$62.76	$650,005	90,878
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M	Ordinary Shares	21,129	$38.81	$820,016	80,521
2017-03-20	TEN HOEDT ROB	EVP & President EMEA	Exercise / conversion M	Ordinary Shares	8,154	$37.53	$306,020	59,392
2017-03-15	ISHRAK OMAR	Chairman & CEO	Exercise / conversion M · derivative	Stock Option (Right to Buy)	75,000	$0.00	$0	215,338
2017-03-15	ISHRAK OMAR	Chairman & CEO	Open-market sell S	Ordinary Shares	95,000	$82.82	$7,868,014	550,616
2017-03-15	ISHRAK OMAR	Chairman & CEO	Exercise / conversion M	Ordinary Shares	75,000	$38.81	$2,910,750	645,616
2017-03-02	HOGAN RANDALL J	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	15,109	$0.00	$0	0
2017-03-02	HOGAN RANDALL J	Dir	Exercise / conversion M	Ordinary Shares	15,109	$27.38	$413,684	32,458
2017-03-01	ARNOLD CRAIG	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	15,109	$0.00	$0	0
2017-03-01	ARNOLD CRAIG	Dir	Other disposed transaction F	Ordinary Shares	6,974	$82.07	$572,356	25,939
2017-03-01	ARNOLD CRAIG	Dir	Exercise / conversion M	Ordinary Shares	15,109	$27.38	$413,684	32,913
2017-03-01	ARNOLD CRAIG	Dir	Other disposed transaction F	Ordinary Shares	6,981	$82.07	$572,931	25,932
2017-02-17	Hanson Bryan C	EVP, President, MITG	Other disposed transaction F	Ordinary Shares	1,751	$78.88	$138,119	148,403
2017-01-05	Lenehan James T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	801	$0.00	$0	0
2017-01-05	Lenehan James T	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,586	$0.00	$0	801
2017-01-05	Lenehan James T	Dir	Exercise / conversion M	Ordinary Shares	801	$54.14	$43,366	43,639
2017-01-05	Lenehan James T	Dir	Exercise / conversion M	Ordinary Shares	2,586	$54.14	$140,006	42,838
2016-12-30	Ellis Gary Lee	EVP & Global Ops and IT	Equity grant / award G	Ordinary Shares	10,000	$0.00	$0	180,718
2016-12-13	POZEN ROBERT C	Dir	Open-market buy P	Ordinary Shares	13,660	$73.21	$999,983	67,223
2016-12-01	Hanson Bryan C	EVP, President, MITG	Other disposed transaction F	Ordinary Shares	4,155	$71.88	$298,661	149,586
2016-11-23	Lenehan James T	Dir	Open-market buy P	Ordinary Shares	2,000	$73.27	$146,533	40,252
2016-10-28	Surface Carol A	SVP, Chief HR Officer	Other disposed transaction F	Ordinary Shares	12,618	$81.93	$1,033,793	56,346
2016-09-27	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Open-market sell S	Ordinary Shares	17,141	$86.70	$1,486,056	107,085
2016-09-26	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M · derivative	Stock Option (Right to Buy)	30,624	$0.00	$0	0
2016-09-26	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Open-market sell S	Ordinary Shares	25,199	$86.67	$2,183,997	124,226
2016-09-26	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M	Ordinary Shares	30,624	$35.92	$1,100,014	149,425
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,813	$0.00	$0	0
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,671	$0.00	$0	0
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,590	$0.00	$0	0
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,010	$0.00	$0	0
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,977	$0.00	$0	0
2016-09-15	Powell Kendall J	Dir	Open-market sell S	Ordinary Shares	7,907	$85.44	$675,614	26,375
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M	Ordinary Shares	1,813	$44.13	$80,008	34,282
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M	Ordinary Shares	2,671	$29.96	$80,023	32,469
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M	Ordinary Shares	1,590	$50.34	$80,041	29,798
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M	Ordinary Shares	1,010	$52.84	$53,368	28,208
2016-09-15	Powell Kendall J	Dir	Exercise / conversion M	Ordinary Shares	2,977	$51.61	$153,643	27,198
2016-08-29	Hanson Bryan C	EVP, President, MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	15,000	$0.00	$0	21,802
2016-08-29	Hanson Bryan C	EVP, President, MITG	Open-market sell S	Ordinary Shares	15,000	$87.00	$1,305,000	153,192
2016-08-29	Hanson Bryan C	EVP, President, MITG	Exercise / conversion M	Ordinary Shares	15,000	$29.52	$442,800	168,192
2016-08-16	OLEARY DENISE M	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,493	$0.00	$0	0
2016-08-16	OLEARY DENISE M	Dir	Exercise / conversion M	Ordinary Shares	1,493	$46.91	$70,037	52,423
2016-08-01	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Equity grant / award A · derivative	Stock Option (Right to Buy)	1,136	$0.00	$0	1,136
2016-08-01	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Equity grant / award A · derivative	Stock Option (Right to Buy)	39,368	$0.00	$0	39,368
2016-08-01	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Equity grant / award A	Ordinary Shares	9,842	$0.00	$0	118,801
2016-07-29	TEN HOEDT ROB	EVP & President EMEA	Other disposed transaction F	Ordinary Shares	245	$87.63	$21,469	30,789
2016-07-28	Lerman Bradley E	SVP General Counsel & Corp Sec	Other disposed transaction F	Ordinary Shares	7,636	$87.42	$667,539	40,725
2016-07-26	Hanson Bryan C	EVP, President, MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	15,000	$0.00	$0	36,802
2016-07-26	Hanson Bryan C	EVP, President, MITG	Open-market sell S	Ordinary Shares	15,000	$87.00	$1,305,000	93,717
2016-07-26	Hanson Bryan C	EVP, President, MITG	Exercise / conversion M	Ordinary Shares	15,000	$29.52	$442,800	108,717
2016-07-15	Martha Geoffrey	EVP & GroupPres Restora Therap	Open-market sell S	Ordinary Shares	3,766	$88.26	$332,402	26,273
2016-07-13	Ellis Gary Lee	EVP & Global Ops and IT	Exercise / conversion M · derivative	Stock Option (Right to Buy)	41,068	$0.00	$0	0
2016-07-13	Ellis Gary Lee	EVP & Global Ops and IT	Open-market sell S	Ordinary Shares	35,495	$88.64	$3,146,206	180,939
2016-07-13	Ellis Gary Lee	EVP & Global Ops and IT	Exercise / conversion M	Ordinary Shares	41,068	$48.70	$2,000,012	216,434
2016-07-06	Surface Carol A	SVP, Chief HR Officer	Open-market sell S	Ordinary Shares	9,787	$87.08	$852,273	59,784
2016-07-05	Hanson Bryan C	EVP, President, MITG	Exercise / conversion M · derivative	Stock Option (Right to Buy)	15,272	$0.00	$0	0
2016-07-05	Hanson Bryan C	EVP, President, MITG	Open-market sell S	Ordinary Shares	15,272	$87.11	$1,330,344	93,717
2016-07-05	Hanson Bryan C	EVP, President, MITG	Exercise / conversion M	Ordinary Shares	15,272	$27.29	$416,773	108,989
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,813	$0.00	$0	0
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,671	$0.00	$0	0
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,590	$0.00	$0	0
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,010	$0.00	$0	0
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M · derivative	Stock Option (Right to Buy)	1,493	$0.00	$0	0
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M	Ordinary Shares	1,813	$44.13	$80,008	64,244
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M	Ordinary Shares	2,671	$29.96	$80,023	62,431
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M	Ordinary Shares	1,590	$50.34	$80,041	59,760
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M	Ordinary Shares	1,010	$52.84	$53,368	58,170
2016-06-24	ANDERSON RICHARD H	Dir	Exercise / conversion M	Ordinary Shares	1,493	$46.91	$70,037	57,160
2016-06-20	PARKHILL KAREN L	EVP & Chief Financial Officer	Equity grant / award A	Ordinary Shares	52,090	$0.00	$0	52,176
2016-06-03	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M · derivative	Stock Option (Right to Buy)	35,872	$0.00	$0	0
2016-06-03	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M · derivative	Stock Option (Right to Buy)	23,028	$0.00	$0	0
2016-06-03	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Open-market sell S	Ordinary Shares	49,905	$82.60	$4,122,153	113,614
2016-06-03	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M	Ordinary Shares	35,872	$36.24	$1,300,001	163,519
2016-06-03	Kuntz Richard	SrVP & Chief Scien, Clin, Reg	Exercise / conversion M	Ordinary Shares	23,028	$47.77	$1,100,048	127,647
2016-06-01	TEN HOEDT ROB	EVP & President EMEAC	Exercise / conversion M · derivative	Stock Option (Right to Buy)	7,656	$0.00	$0	0
2016-06-01	TEN HOEDT ROB	EVP & President EMEAC	Exercise / conversion M · derivative	Stock Option (Right to Buy)	2,760	$0.00	$0	0
2016-06-01	TEN HOEDT ROB	EVP & President EMEAC	Open-market sell S	Ordinary Shares	7,656	$80.52	$616,488	30,939
2016-06-01	TEN HOEDT ROB	EVP & President EMEAC	Exercise / conversion M	Ordinary Shares	7,656	$35.92	$275,004	38,595
2016-06-01	TEN HOEDT ROB	EVP & President EMEAC	Open-market sell S	Ordinary Shares	2,760	$80.50	$222,190	30,939
2016-06-01	TEN HOEDT ROB	EVP & President EMEAC	Exercise / conversion M	Ordinary Shares	2,760	$36.24	$100,022	33,699
2016-06-01	TEN HOEDT ROB	EVP & President EMEAC	Open-market sell S	Ordinary Shares	1,684	$80.59	$135,722	30,939
2016-05-02	REDDY PREETHA	Dir	Equity grant / award A	Ordinary Shares	2,206	$0.00	$0	7,823
2016-04-27	HOGAN RANDALL J	Dir	Other disposed transaction F	Ordinary Shares	221	$79.45	$17,558	15,108

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count